Paul Tudor Jones’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Paul Tudor Jones’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-32,230	Closed	-$2.42M	–	2853
2022 Q2	$2.42M	Buy	+32,230	New	+$1.43M	0.06%	422
2021 Q2	–	Sell	-12,107	Closed	-$1.15M	–	2105
2021 Q1	$1.15M	Buy	12,107 +2,935	+32%	+$349K	0.02%	774
2020 Q4	$1.12M	Buy	+9,172	New	+$1M	0.03%	652

Paul Tudor Jones's TPTX Position: Q3 2022 in Review

Paul Tudor Jones sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 32,230 shares — an estimated $2.42M sold.

Paul Tudor Jones first reported a position in TPTX in Q4 2020 and held it in 3 quarters. The position peaked at $2.42M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Paul Tudor Jones reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Paul Tudor Jones sold 32,230 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $2.42M.
Paul Tudor Jones first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
Paul Tudor Jones's Turning Point Therapeutics, Inc. Common Stock position peaked at $2.42M in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Tudor Investment Corp's 13F filing for Q3 2022, filed 14 Nov 2022.